SEARCH RESULTS FOR: "Tag: ESPR"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2022(1)
2019(2)
2018(3)
2017(3)
2016(1)
2015(7)
CATEGORIES
Analyst Update(2)
Analyst Upgrades(1)
Buzz Stocks(4)
Ezines(1)
General(2)
Intraday Option Activity(1)
Midday Market Check(2)
Opening View(1)
Stocks On the Move(5)
Technical Analysis(1)

12/7/2022 12:16 PM
At least two biotech stocks are triggering an options trading frenzy today, with Prometheus Biosciences Inc (NASDAQ:RXDX) and Esperion Therapeutics Inc (NASDAQ:ESPR) moving in opposite directions foll...
5/29/2019 12:56 PM
This morning, Goldman Sachs weighed in on two pharma stocks, downgrading Clovis Oncology Inc (NASDAQ:CLVS) and Esperion Therapeutics Inc (NASDAQ:ESPR) to "sell." Regarding the former, Goldman believes...
5/6/2019 9:55 AM
Near the top of the Nasdaq today sits Esperion Therapeutics Inc (NASDAQ:ESPR), after the Food and Drug Administration (FDA) accepted marketing applications for the company's cholesterol drug. At last...
5/2/2018 3:22 PM
The Nasdaq is outperforming today, thanks to a positive earnings reaction for Apple (AAPL). Nevertheless, drug stocks Akorn, Inc. (NASDAQ:AKRX), Esperion Therapeutics Inc (NASDAQ:ESPR), and Gilead Sc...
3/27/2018 2:03 PM
The Dow is holding higher this afternoon thanks to a strong move from GE stock. Three other names making notable moves today are drug stocks Esperion Therapeutics Inc (NASDAQ:ESPR), Arrowhead Pharm...